News | tctmd.com

In-Depth

See all

Feature

The Right Anticoagulation Dose in COVID-19? Final Answer Remains Elusive

By Todd Neale

Feature

Cardiac Care Feels Staffing Crunch as Big Money Converts COVID-19 Travelers

By Shelley Wood

Feature

$45 Million OHSU Lawsuit Hits a Nerve for #CardiologyToo

Sexual harassment policies don’t always work to plan, as this explosive case makes clear. When hospitals don’t listen, who will?

By Caitlin E. Cox

March 05, 2021

$45 Million OHSU Lawsuit Hits a Nerve for #CardiologyToo

News

Low Incidence of Myocarditis Among Pro Athletes Diagnosed With COVID-19

The reassuring data also highlight the importance of following appropriate screening protocols and avoiding blanket use of MRI.

By Michael O'Riordan

March 05, 2021

Low Incidence of Myocarditis Among Pro Athletes Diagnosed With COVID-19

News

COVID-19: TCTMD’s Daily Dispatch for March 5

More warnings from Brazil, vaccine maneuvers, questions about the pandemic’s origins, vaccinated great apes, and more.

By Todd Neale

March 05, 2021

COVID-19: TCTMD’s Daily Dispatch for March 5

News

Cardiometabolic Diseases Contribute to Bulk of COVID-19 Hospitalizations

The study is a “wake-up call” that improving metabolic health may prevent severe disease in this pandemic and others to come.

By Todd Neale

March 04, 2021

Cardiometabolic Diseases Contribute to Bulk of COVID-19 Hospitalizations

News

Daily Fruit and Vegetable Intake Linked to Lower Mortality

While two fruit and three vegetable servings per day was found to be optimal, potato-lovers might be disappointed.

By L.A. McKeown

March 04, 2021

Daily Fruit and Vegetable Intake Linked to Lower Mortality

News

MI Hospitalizations Down 20% at COVID-19 Peak in Italy, With a Heavy Cost

During the same period, out-of-hospital cardiac mortality increased, which researchers say was “more than a coincidence.”

By Michael O'Riordan

March 04, 2021

MI Hospitalizations Down 20% at COVID-19 Peak in Italy, With a Heavy Cost

News

EVOLVE Short DAPT in Print: P2Y12 Decisions Can Safely Be Made Case-by-Case

There’s still no formulaic answer to DAPT duration after stenting, but Ajay Kirtane said these data will help clinicians balance risks.

By Yael L. Maxwell

March 03, 2021

EVOLVE Short DAPT in Print: P2Y12 Decisions Can Safely Be Made Case-by-Case

TCTMD Talking Points

FLASH Registry: Acute Hemodynamic Improvement With Percutaneous Mechanical Thrombectomy in a Real-world Pulmonary Embolism Population

News

Big Drops in LDL Cholesterol With Inclisiran, but US Clinicians Still Await Drug’s Approval

Inclisiran reduced LDL levels by more than 50%, and physicians hope the drug is not only approved but also not priced too high.

By Michael O'Riordan

March 03, 2021

Big Drops in LDL Cholesterol With Inclisiran, but US Clinicians Still Await Drug’s Approval

News

Lower Dose of Edoxaban Supported in ENGAGE-AF-TIMI 48 Analysis

Even so, the approved higher dose remains the standard therapy for the vast majority of patients, the researchers say.

By Todd Neale

March 02, 2021

Lower Dose of Edoxaban Supported in ENGAGE-AF-TIMI 48 Analysis

News • Interventional

Published 2-Year Partner 3 Data Shed New Light on TAVI, SAVR Choice in Low-risk Patients

Martin Leon cautions against “overinterpreting” the numbers, since the full low-risk TAVI story will take years to complete.

By Yael L. Maxwell

March 02, 2021

Published 2-Year Partner 3 Data Shed New Light on TAVI, SAVR Choice in Low-risk Patients

Editor's Corner

TCTMD’s Top 10 Most Popular Stories for February 2021

Are cardiologists tiring of COVID-19 coverage and keen to get back to the practice of cardiology? Our February Top 10 says yes.

By Shelley Wood

March 02, 2021

TCTMD’s Top 10 Most Popular Stories for February 2021

See All News

SCAI 2020

May 14

May 16, 2020

RSIP Vision Announces Sophisticated AI-Based Tool for Coronary Artery Analysis and Intervention Planning

New module utilizes state-of-the-art deep learning (DL) algorithms combined with classic computer vision methods to create a 3D model of the coronary arteries to better visualize artery structure and reduce procedural risks to patients

MagicTouch SCB Granted 'Breakthrough Device Designation' for the treatment of Small Coronary Artery Lesions.

Efemoral Medical Announces Successful First-In-Human Use of The Efemoral™ Vascular Scaffold System

New bioresorbable treatment option aims to improve outcomes for patients suffering from peripheral arterial disease

Advertisement

In-Depth

The Right Anticoagulation Dose in COVID-19? Final Answer Remains Elusive

Cardiac Care Feels Staffing Crunch as Big Money Converts COVID-19 Travelers

$45 Million OHSU Lawsuit Hits a Nerve for #CardiologyToo

Low Incidence of Myocarditis Among Pro Athletes Diagnosed With COVID-19

COVID-19: TCTMD’s Daily Dispatch for March 5

Cardiometabolic Diseases Contribute to Bulk of COVID-19 Hospitalizations

Daily Fruit and Vegetable Intake Linked to Lower Mortality

MI Hospitalizations Down 20% at COVID-19 Peak in Italy, With a Heavy Cost

EVOLVE Short DAPT in Print: P2Y12 Decisions Can Safely Be Made Case-by-Case

FLASH Registry: Acute Hemodynamic Improvement With Percutaneous Mechanical Thrombectomy in a Real-world Pulmonary Embolism Population

Big Drops in LDL Cholesterol With Inclisiran, but US Clinicians Still Await Drug’s Approval

Lower Dose of Edoxaban Supported in ENGAGE-AF-TIMI 48 Analysis

Published 2-Year Partner 3 Data Shed New Light on TAVI, SAVR Choice in Low-risk Patients

TCTMD’s Top 10 Most Popular Stories for February 2021

Advertisement

@tctmd

Conference Coverage

TVT Connect 2020

HRS 2020

SCAI 2020

Around the Web

Advertisement

Advertisement

In-Depth

Search News

Sign Up for Our Newsletter

Advertisement

@tctmd

Conference Coverage

Around the Web

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content